Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
This review summarizes the recent findings of a vast array of studies conducted on androgen receptor-positive triple-negative breast cancer (AR-positive TNBC) to provide a better understanding of this specific breast cancer subgroup. AR expression is correlated with higher age, lower histological gr...
Main Authors: | Maša Brumec, Monika Sobočan, Iztok Takač, Darja Arko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1642 |
Similar Items
-
Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
by: Fatma Zakaria, et al.
Published: (2016-06-01) -
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
by: Mirco Pistelli, et al.
Published: (2014-06-01) -
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease
by: Maria Vittoria Dieci, et al.
Published: (2019-06-01) -
Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01) -
Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple–negative breast cancer?
by: Ana Tečić-Vuger, et al.
Published: (2020-01-01)